May 31, 2021
Yoshindo and partner Teijin Pharma said on May 28 that they are temporarily suspending shipments of their Enbrel (etanercept) biosimilar products in Japan as the spread of COVID-19 in India has crippled the supply chain, making it difficult to secure...read more